Across TCGA pan-cancer cohorts, WDR41 Mutation is linked to patient survival in 7 of 34 cancer types, making it a survival-associated WDR41 data layer compared with 27 for mass-spec protein and 6 for mass-spec protein.
The strongest signal is observed in thymoma (THYM), where higher WDR41 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated WDR41 expression acts as an unfavorable survival marker, although some lineages such as UCEC and BLCA show a favorable association.
THYM, ESCA, and HNSC are the cancer types where WDR41 Mutation most reproducibly stratifies survival.
Mutation survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.